These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8234407)

  • 1. Transdermal delivery of drugs. Part 7: Evaluation of the adhesive layer of matrices for TDS.
    Ducková K; Hadzimová D; Kućera J; Heinrich J
    Pharmazie; 1993 Sep; 48(9):705-6. PubMed ID: 8234407
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioadhesive film for dermal and transdermal drug delivery.
    Padula C; Nicoli S; Aversa V; Colombo P; Falson F; Pirot F; Santi P
    Eur J Dermatol; 2007; 17(4):309-12. PubMed ID: 17540637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of adhesive properties of transdermal therapeutic systems containing nitroglycerin.
    Minghetti P; Casiraghi A; Cilurzo F; Montanari L
    Boll Chim Farm; 2001; 140(2):63-7. PubMed ID: 11417388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and in vivo evaluation of an indapamide transdermal patch.
    Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
    Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of a new testosterone transdermal delivery system, TDS-testosterone in healthy males.
    Chik Z; Johnston A; Tucker AT; Chew SL; Michaels L; Alam CA
    Br J Clin Pharmacol; 2006 Mar; 61(3):275-9. PubMed ID: 16487220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.
    Wokovich AM; Prodduturi S; Doub WH; Hussain AS; Buhse LF
    Eur J Pharm Biopharm; 2006 Aug; 64(1):1-8. PubMed ID: 16797171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new transdermal delivery system for pilocarpine in glaucoma treatment.
    Dinslage S; Diestelhorst M; Hille T; Otto K
    Ger J Ophthalmol; 1996 Sep; 5(5):275-80. PubMed ID: 8911949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic delivery systems: a new approach to evaluate physical properties of transdermal delivery systems (TDS).
    Ehrlich A; Henkel-Ernst J; Schaefer A; Assmussen B; Lücker PW
    Methods Find Exp Clin Pharmacol; 1999; 21(1):69-71. PubMed ID: 10222451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-layer transdermal film containing lidocaine: modulation of drug release.
    Padula C; Nicoli S; Colombo P; Santi P
    Eur J Pharm Biopharm; 2007 Jun; 66(3):422-8. PubMed ID: 17196804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample preparation optimization for assay of active pharmaceutical ingredients in a transdermal drug delivery system using experimental designs.
    Li W; Nadig D; Rasmussen HT; Patel K; Shah T
    J Pharm Biomed Anal; 2005 Mar; 37(3):493-8. PubMed ID: 15740909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of transdermal drug delivery: chemical and physical approaches.
    Asbill CS; El-Kattan AF; Michniak B
    Crit Rev Ther Drug Carrier Syst; 2000; 17(6):621-58. PubMed ID: 11204737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal drug delivery: clinical considerations for the obstetrician-gynecologist.
    Potts RO; Lobo RA
    Obstet Gynecol; 2005 May; 105(5 Pt 1):953-61. PubMed ID: 15863530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of residual solvents on the physical properties of transdermal drug delivery systems.
    Mazumder S; Shakleya D; Mattson S; Ashraf M; Faustino P; Pavurala N
    Int J Pharm; 2020 Oct; 588():119713. PubMed ID: 32755689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transdermal therapeutic systems for drug administration].
    Hupfeld S; Gravem H
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):532-3. PubMed ID: 19282891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol.
    Gao Y; Liang J; Liu J; Xiao Y
    Int J Pharm; 2009 Jul; 377(1-2):128-34. PubMed ID: 19463930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal drug delivery: a new frontier in the administration of therapeutic drugs to veterinary species.
    Villarino N; Landoni MF
    Vet J; 2006 Sep; 172(2):200-1. PubMed ID: 16324860
    [No Abstract]   [Full Text] [Related]  

  • 19. Buprenorphine and the transdermal system: the ideal match in pain management.
    Budd K
    Int J Clin Pract Suppl; 2003 Feb; (133):9-14; discussion 23-4. PubMed ID: 12665118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of a combined percutaneous local anaesthetic and the TDS system for venepuncture.
    Tucker AT; Chik Z; Michaels L; Kirby K; Seed MP; Johnston A; Alam CA
    Anaesthesia; 2006 Feb; 61(2):123-6. PubMed ID: 16430563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.